Clover Health Investments SG&A Expenses 2020-2024 | CLOV

Clover Health Investments sg&a expenses from 2020 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
Clover Health Investments Annual SG&A Expenses
(Millions of US $)
2023 $445
2022 $487
2021 $446
2020 $192
2019 $187
Clover Health Investments Quarterly SG&A Expenses
(Millions of US $)
2024-03-31 $104
2023-12-31 $111
2023-09-30 $102
2023-06-30 $105
2023-03-31 $127
2022-12-31 $124
2022-09-30 $118
2022-06-30 $118
2022-03-31 $127
2021-12-31 $114
2021-09-30 $119
2021-06-30 $108
2021-03-31 $105
2020-12-31 $55
2020-09-30 $46
2020-06-30 $41
2020-03-31 $50
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.428B $2.034B
Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $37.763B 20.73
Inspire Medical Systems (INSP) United States $5.181B 0.00
Axonics (AXNX) United States $3.439B 0.00
10x Genomics (TXG) United States $3.145B 0.00
IRhythm Technologies (IRTC) United States $3.107B 0.00
Azenta (AZTA) United States $2.928B 159.12
Olink Holding AB (publ) (OLK) Sweden $2.910B 0.00
Enovis (ENOV) United States $2.800B 20.75
Hims & Hers Health (HIMS) United States $2.768B 0.00
Privia Health (PRVA) United States $2.139B 120.20
Schrodinger (SDGR) United States $1.673B 0.00
Omnicell (OMCL) United States $1.389B 48.02
Phreesia (PHR) United States $1.238B 0.00
Standard BioTools (LAB) United States $0.699B 0.00
Fulgent Genetics (FLGT) United States $0.652B 0.00
Definitive Healthcare (DH) United States $0.610B 0.00
Talkspace (TALK) United States $0.483B 0.00
Health Catalyst (HCAT) United States $0.394B 0.00
Pulmonx (LUNG) United States $0.340B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.314B 0.00
P3 Health Partners (PIII) United States $0.231B 0.00
Butterfly Network (BFLY) United States $0.205B 0.00
Outset Medical (OM) United States $0.169B 0.00
American Well (AMWL) United States $0.152B 0.00
TruBridge (TBRG) United States $0.123B 5.26
Augmedix (AUGX) United States $0.122B 0.00
MSP Recovery (LIFW) United States $0.120B 0.00
111 (YI) China $0.095B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.073B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.060B 0.00
Zepp Health (ZEPP) China $0.054B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
EUDA Health Holdings (EUDA) Singapore $0.046B 0.00
Movano (MOVE) United States $0.039B 0.00
Akili (AKLI) United States $0.035B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.033B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
CareCloud (CCLD) United States $0.021B 0.00
Streamline Health Solutions (STRM) United States $0.021B 0.00
Cue Health (HLTH) United States $0.021B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Biotricity (BTCY) United States $0.011B 0.00
Syra Health (SYRA) United States $0.009B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.001B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00